Submission Details
| 510(k) Number | K132281 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 23, 2013 |
| Decision Date | August 30, 2013 |
| Days to Decision | 38 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K132281 is an FDA 510(k) clearance for the ReVive PV (Peripheral Vasculature) Thrombectomy Device, a Peripheral Mechanical Thrombectomy With Aspiration (Class II — Special Controls, product code QEW), submitted by Codman & Shurtleff, Inc. (Raynham, US). The FDA issued a Cleared decision on August 30, 2013, 38 days after receiving the submission on July 23, 2013. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.5150.
| 510(k) Number | K132281 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 23, 2013 |
| Decision Date | August 30, 2013 |
| Days to Decision | 38 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | QEW — Peripheral Mechanical Thrombectomy With Aspiration |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.5150 |
| Definition | To Mechanically Disrupt Thrombus And/or Debris Prior To Removal From The Peripheral Vasculature Through Aspiration. |